News
LABT ▼ -6.9% - Lakewood-Amedex Biotherapeutics, Inc.
LABT ▼ -6.9% - Lakewood-Amedex Biotherapeutics, Inc.
$LABT LABT - Lakewood-Amedex Biotherapeutics Announces Positive Preclinical Data in Urinary Tract and Pulmonary Infection Indications with Bisphosphocin® Compounds
07-OCT-2026 08:03 AM ET
Share this post
More filings for $LABT
LABT ▼ -5.3% - Lakewood-Amedex Biotherapeutics, Inc.Oct 1, 2026LABT ▲ +99.4% - Lakewood-Amedex Biotherapeutics, Inc.Sep 28, 2026LABT ▲ +88.0% - Lakewood-Amedex Biotherapeutics, Inc.Sep 28, 2026LABT ▲ +10.6% - Lakewood-Amedex Biotherapeutics, Inc.Sep 24, 2026LABT ▲ +12.6% - Lakewood-Amedex Biotherapeutics, Inc.Sep 21, 2026LABT ▲ +1.1% - Lakewood-Amedex Biotherapeutics, Inc.Sep 8, 2026
View full $LABT filing history →💬 Comments
Loading comments…
Leave a comment